SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

28 October 2008

 

 

PROTHERICS PLC

(Translation of Registrant’s Name Into English)

 

 

The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F       X              Form 40-F               

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):             

 

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under
            the Securities Exchange Act of 1934.

 

Yes                     No          X     

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-              .

 

 

The Registrant is furnishing a copy of its announcements as reported to the Company Announcements Office of the London Stock Exchange.

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       

 

PROTHERICS PLC

       

Date: 28 October 2008

 

By:

 

/s/ Rolf Soderstrom


       

Rolf Soderstrom

       

Finance Director

 

                                                 Protherics PLC

                              Notification of Major Interest in Shares

London, UK; Brentwood, TN, US; 28 October 2008 -  Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company
focused on critical care and cancer, announces that the following notification of interest in the ordinary share capital of the Company was received today 
from Aviva plc.


1. Reason for the notification        (please tick the appropriate box or boxes)



 


An acquisition or disposal voting rights 


 


An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are attached


 


An event changing the breakdown of voting rights


 


Other (please specify): INCREASE IN NUMBER OF VOTING
SHARES IN ISSUE



2. Full name of person(s) subject to the notification obligation:


Aviva plc & its subsidiaries 


3. Full name of shareholder(s) (if different from 2.):

Registered Holder:

BNY Norwich Union
Nominees Limited     
  6,033,442*

Chase GA Group
Nominees Limited  
19,592,672*

Chase Nominees Limited
881,559*

CUIM Nominee Limited
4,416,028*

Vidacos Nominees Limited
65,125*

*denotes direct interest  

BNP Paribas - London
636,429

Chase Nominees Limited 
3,171,774

State Street Nominees Limited  
9,428,137

Vidacos Nominees
Limited 
1,746,000    


4. Date of the transaction (and date on which the threshold is crossed or reached if different):


27 October 2008


5. Date on which issuer notified:


28 October 2008


6. Threshold(s) that is/are crossed or reached:


9% to 8% Change at Direct Interest level   


7. Notified details:



 




A: Voting rights attached to shares

Class/type of shares 

if possible using
the ISIN CODE

     Situation previous      
     to the Triggering
     transaction 

     Resulting situation after the triggering transaction    

     Number    
     of
     Shares 

     Number
     of Voting    
     Rights 

     Number of    
     shares 

     Number of voting    
     rights

     % of voting rights    

     Direct

     Direct  

     Indirect      

     Direct    

     Indirect    


Ordinary Shares

GB0007029209

 

   
     46,722,061    




     46,722,061    

   


     30,988,826    

 

   
     30,988,826    

   


     14,982,340    

 

   
     8.84%    

   


     4.28%    




B: Financial Instruments

Resulting situation after the triggering transaction 

Type of financial
instrument  

     Expiration    
     date 

     Exercise/
     Conversion Period/    
     Date
 

     Number of voting
     rights that may be
     acquired if the
     instrument is exercised/    
     converted. 

     % of voting    
     rights



N/A


Total (A+B)

Number of voting rights    

     % of voting rights

   
45,971,166

   
     13.12%




8. Chain of controlled undertakings through which the voting rights and/or the financial
instruments are effectively held, if applicable :


The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the
following chain of controlled undertakings:-

Aviva Investors Global Services Limited:

  • Aviva plc (Parent Company)

  • Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

  • Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

  • Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)




Proxy Voting:


9. Name of the proxy holder:

   
See Section 3


10. Number of voting rights proxy holder will cease to hold:

   


11. Date on which proxy holder will cease to hold voting rights:

   



12. Additional information:

                        Figures are based on a revised total number of
                        voting rights of 340,427,481



 

                                                                    | Ends |


For further information please contact:

Protherics 

 

Nick Staples, Director of Corporate Affairs

                         +44 (0) 7919 480510  

Julie Vickers, Company Secretary 

                         +44 (0)1928 518010

 

 

Financial Dynamics  - press enquiries

 

London: Ben Atwell, Lara Mott

                         +44 (0) 20 7831 3113 

New York: John Capodanno

                         +1 212 850 5600


Or visit   www.protherics.com

Protherics (NASDAQ:PTIL)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Protherics Charts.
Protherics (NASDAQ:PTIL)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Protherics Charts.